Umang Swami

Umang Swami, MD, MSCI, FASCO is an Associate Professor in the Department of Internal Medicine at the University of Utah's Huntsman Cancer Institute. A specialist in medical oncology with a focus on genitourinary cancers, he completed his medical education at Sawai Man Singh Medical College, India, followed by residency at St. Barnabas Hospital, NY, and a hematology-oncology fellowship at the University of Iowa. His work spans prostate cancer, urothelial carcinoma, renal cell carcinoma, and immune checkpoint inhibitors, with over 150 peer-reviewed publications and leadership roles in ASCO guideline panels.

• Education:
  • M.D. from Sawai Man Singh Medical College, India
  • M.S.C.I. from University of Iowa College of Public Health
  • Hematology-Oncology Fellowship at University of Iowa Hospitals and Clinics

His research emphasizes genomic profiling, treatment outcomes, and biomarker discovery in metastatic and castration-resistant cancers. Recent articles highlight immunotherapy combinations, PARP inhibitors, and real-world treatment disparities. He serves on institutional review boards and contributes to clinical trial design, including the PemCab and RadSABR studies.

Scientific Awards:

• Fellow of the American Society of Clinical Oncology (FASCO)

He mentors medical students and fellows, integrating machine learning applications for cardiovascular risk scoring in cancer patients. His work bridges clinical practice with translational research, addressing challenges in drug development and immune-related adverse events.